3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
9
Congenital Abnormalities
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Myeloid, Acute
8
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
7
Multiple Myeloma
6
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, Mantle-Cell
6
Leukemia
6
Sezary Syndrome
5
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Mycosis Fungoides
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma
5
Burkitt Lymphoma
5
Waldenstrom Macroglobulinemia
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, Extranodal NK-T-Cell
4
Lung Neoplasms
4
Leukemia, Myelomonocytic, Chronic
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Blast Crisis
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms, Plasma Cell
3
Leukemia, Myeloid, Chronic-Phase
3
Interventions
pembrolizumab
37
Paclitaxel
36
Carboplatin
31
Cyclophosphamide
22
Albumin-Bound Paclitaxel
20
atezolizumab
16
130-nm albumin-bound paclitaxel
16
Taxes
15
Doxorubicin
15
Cisplatin
13
Capecitabine
13
Nivolumab
10
Docetaxel
8
olaparib
7
Gemcitabine
6
Everolimus
6
talazoparib
5
durvalumab
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Bevacizumab
5
veliparib
4
spartalizumab
4
sacituzumab govitecan
4
pegfilgrastim
4
liposomal doxorubicin
4
eribulin
4
Specimen Handling
4
Immunoglobulin G
4
trilaciclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Triple Negative Breast Neoplasms
×
Flow Cytometry
×
Clear all
No trials found.